Philips, established in 1891 and headquartered in Amsterdam, Netherlands, is a global leader in health technology, committed to improving people's health and well-being through meaningful innovation. The company's portfolio includes diagnostic imaging, image-guided therapy, patient monitoring, health informatics, and consumer health and home care products. Philips aims to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. Recognized for its commitment to sustainability and social responsibility, Philips has been named a top employer by Forbes and ranked as the highest medical technology company among Clarivate's Top 100 Global Innovators in 2025.
Royal Philips introduces AI-assisted imaging software to support minimally invasive mitral valve repair procedures within a connected cardiology ecosystem.
Royal Philips and Amazon Web Services deploy a cloud-enabled digital pathology platform to support healthcare organizations in scaling digital diagnostics and AI-enabled workflows.
Philips introduces SmartHeart, an AI-based cardiac MR planning technology cleared by the U.S. FDA to automate scan setup and improve workflow consistency in cardiac imaging.
SpectraWAVE is AI-powered HyperVue and X1-FFR technologies, integrating them with the Azurion platform to create a comprehensive, next-generation coronary imaging and physiology portfolio.
New advanced visualization and cloud-based capabilities showcased at RSNA 2025 aim to simplify multi-modality imaging, accelerate reporting, and enhance decision-making across clinical teams.
Used across complex vascular procedures, this real-time 3D navigation system advances image-guided therapy by reducing radiation exposure, improving orientation and integrating directly with established interventional workflows.